Fully integrated and automated centrifugal microfluidic chip for point-of-care multiplexed molecular diagnostics

• DOI: 10.1016/j.bios.2024.116240
• Publication Date: 2024-03-28T14:47:25Z
• Authors: Yujin Xiao; Mengfan Zhou; Changgen Liu; Siyu Gao; Chao Wan; Shunji Li; Chenxi Dai; Wei Du; Xiaojun Feng; Yiwei Li; Peng Chen; Bi-Feng Liu
• Keywords: Point-of-Care Testing; Point-of-Care Systems; Nucleic Acids; Lab-On-A-Chip Devices; Microfluidics; Escherichia coli; Microbial Sensitivity Tests; Biosensing Techniques; Mycobacterium tuberculosis; Pathology, Molecular; Nucleic Acid Amplification Techniques

Public health events caused by pathogens have imposed significant economic and societal burdens. However, conventional methods still face challenges including complex operations, the need for trained operators, and sophisticated instruments. Here, we proposed a fully integrated and automated centrifugal microfluidic chip, also termed IACMC, for point-of-care multiplexed molecular diagnostics by harnessing the advantages of active and passive valves. The IACMC incorporates multiple essential components including a pneumatic balance module for sequential release of multiple reagents, a pneumatic centrifugation-assisted module for on-demand solution release, an on-chip silicon membrane module for nucleic acid extraction, a Coriolis force-mediated fluid switching module, and an amplification module. Numerical simulation and visual validation were employed to iterate and optimize the chip's structure. Upon sample loading, the chip automatically executes the entire process of bacterial sample lysis, nucleic acid capture, elution quantification, and isothermal LAMP amplification. By optimizing crucial parameters including centrifugation speed, direction of rotation, and silicone membrane thickness, the chip achieves exceptional sensitivity (twenty-five Salmonella or forty Escherichia coli) and specificity in detecting Escherichia coli and Salmonella within 40 min. The development of IACMC will drive advancements in centrifugal microfluidics for point-of-care testing and holds potential for broader applications in precision medicine including high-throughput biochemical analysis immune diagnostics, and drug susceptibility testing.